NCT05323071

Brief Summary

The objective of this study is to compare the use of 24% sucrose in pain control in neonates from 32 weeks of gestation onwards according to the time of administration of sucrose in venous and arterial puncture for blood collection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2022

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

6 months

First QC Date

April 5, 2022

Last Update Submit

January 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain during a painful procedure

    The primary variable is pain, and will be measured by the Premature Infant Pain Profile-Revised (PIPP-R) scale. The score ranges from 0 (no pain or minimal pain) to 21 (maximum pain).

    15 seconds after extraction

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Sucrose will be administered 2 minutes before the puncture following the current protocol of the unit. Venous or arterial puncture will be performed only in case it is required for therapeutic or care purposes.

Other: Sucrose 24%

Experimental Group

EXPERIMENTAL

The administration of the sucrose dose is started by means of a syringe. Once 50% of the dose has been administered, puncture will be performed. The remaining 50% will be administered during the puncture. The pacifier will be left in the mouth until the end of the procedure, facilitating the non-nutritive sucking of the neonate.

Other: Sucrose 24%

Interventions

According to the age of the newborn: 24-26 weeks : 0.1 mL, 27-31weeks : 0.25 mL, 32-36 weeks : 0.5 mL, \>37 weeks : 1 mL

Control GroupExperimental Group

Eligibility Criteria

Age32 Weeks+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Neonates whose parents and/or guardians have signed the informed consent form.

You may not qualify if:

  • Neonates connected to invasive mechanical ventilation.
  • Neonates presenting any type of neurological alteration or showing signs of irritability prior to the puncture.
  • Neonates who have received sedation.
  • Neonates presenting withdrawal syndrome.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Araba-Sede Txagorritxu

Vitoria-Gasteiz, Alava, 01009, Spain

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Neonatal unit nurse

Study Record Dates

First Submitted

April 5, 2022

First Posted

April 12, 2022

Study Start

September 1, 2021

Primary Completion

February 14, 2022

Study Completion

October 11, 2022

Last Updated

January 20, 2023

Record last verified: 2023-01

Locations